IBD & Intestinal Disorders
News
FDA warns about serious GI symptoms with olmesartan
From the AGA Journals
Teduglutide cut parenteral intake at 52 weeks
Major finding: By 52 weeks, 68% of small bowel intestinal failure patients taking teduglutide 0.05 mg/kg per day achieved reductions of 20% or...
From the AGA Journals
IBD gains foothold in Asia
Major finding: In Asia, the crude annual overall incidence of IBD is 1.37/100,000 people (95% CI: 1.25-1.51); in Australia it is 23.67 (95% CI: 18...
News
Extended postoperative VTE prophylaxis appears warranted for IBD patients
Major finding: Compared with patients with colorectal cancer, patients with IBD had a 35% higher risk of venous thromboembolism.
News
Anemia signals greater severity of celiac disease
Major finding: Among patients with celiac disease who presented with anemia, 53% had severe villous atrophy and 56% had osteopenia; the...
News
FDA eases some fecal transplant restrictions
News
H. pylori test OK for people on PPIs, with caution
News
TLR9 agonist active against ulcerative colitis in small study
Major finding: Five of 16 patients available for 3-month follow-up had a sustained clinical response to the TLR9 agonist DIMS0150, compared with...
News
Mesalamine a bust at diverticulitis prevention
Major finding: In a per-protocol analysis, 78.9% of patients on the 5-aminosalicylic acid agent mesalamine had no recurrent diverticulitis after...
Conference Coverage
Risk-based strategy bests drug therapy after Crohn's surgery
Major finding: 49% vs. 67% 18-month recurrence rates for risk-based vs. standard drug therapy.Data source: Data from 174 adults in the randomized...